
Weekly Roundup: March 1-5, 2021
ICYMI, some of this week’s featured content includes content on the benefits of precision medicine, caring for LGBTQ+ patients, a new Legal Eagle column, how trichoscopy can aid with diagnosis of hair disorders, plus more.
This week’s edition of The Mainstream Patient features stories on psoriatic arthritis diagnosis, treating eczema on darker skin types, the efficacy of pore vacuums, plus more.
In this month's Legal Eagle column, David Goldberg, MD, JD, explains if you can terminate an employee who's COVID-19 diagnosis has negatively affected your practice and led to substantial financial losses.
The investigational neuromodulator, evaluated in clinical trials as a treatment for glabellar lines and as a combined therapy for glabellar, dynamic forehead, and lateral canthal lines, is quickly nearing an approval by the FDA.
According to one expert at the 29th European Academy of Dermatology and Venereology Virtual Congress, trichoscopy (a dermoscopy-based diagnostic method) not only helps diagnose hair disorders and monitor treatment but also predicts treatment efficacy.
This is the first overhaul in a quarter century that simplifies evaluation and management and increases flexibility.
With up to 30% of pediatric health care visits involving skin complaints and fewer than 400 board-certified pediatric dermatologists in the United States, teledermatology offers a valuable tool for increasing access and cutting wait times.
Angelo Landriscina, MD, FAAD, discusses how to care for your LGBTQ+ patients while also effectively addressing their different dermatologic needs.
Taking the polar opposite of a one-size-fits-all approach, clinicians now factor in a patient’s genetic profile, medical history, microbiome composition, lifestyle, and diet, among other parameters, otherwise known as precision medicine.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.


















